Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16282956 | 0.95 | KDM4E (0.34) | KDM4EATML3MBTL1MEN1LMNA | |
| SCHEMBL13444291 | 0.90 | KDM4E (0.33) | KDM4EATML3MBTL1 | |
| SCHEMBL16596544 | 0.90 | KDM4E (0.33) | KDM4EATML3MBTL1MEN1LMNA | |
| SCHEMBL27428711 | 0.89 | KDM4E (0.47) | KDM4EATML3MBTL1KMT2APGR | |
| SCHEMBL22352403 | 0.89 | KDM4E (0.47) | KDM4EATML3MBTL1KMT2APGR | |
| SCHEMBL16314032 | 0.89 | PDK2 (0.33) | KDM4EATML3MBTL1 | |
| SCHEMBL13444277 | 0.89 | PDK2 (0.33) | KDM4EATML3MBTL1 | |
| SCHEMBL18086208 | 0.89 | KDM4E (0.44) | KDM4EATML3MBTL1MEN1LMNA | |
| SCHEMBL14822238 | 0.89 | KDM4E (0.35) | KDM4EATML3MBTL1 | |
| SCHEMBL16675629 | 0.88 | KDM4E (0.34) | KDM4EATML3MBTL1PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180145268-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2018-05-24 | — | — | US | disclosed |
| US-20180145268-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2018-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180145268-A1 | Organic Electroluminescent Materials and Devices | OCIAD2, OCIAD1, SOAT2 | KDM4E 3216/4885ATM 2394/4885L3MBTL1 1280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.